- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Arecor chief financial officer to leave in July after five years | 1 | Alliance News | ||
| Di | Arecor Therapeutics - BOARD CHANGE | - | RNS | ||
| 12.03. | Arecor to develop "holy grail" diabetes treatment with partner TRx | 1 | Alliance News | ||
| 12.03. | Arecor Therapeutics Plc: Arecor And TRx Biosciences Establish Research Collaboration To Develop Oral Glp-1 With Enhanced Bioavailability | 23 | GlobeNewswire (Europe) | Arecor Therapeutics plc("Arecor" or the "Company") ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY Companies to combine proprietary technologies... ► Artikel lesen | |
| 12.03. | Arecor Therapeutics - Arecor and TRx Biosciences research collaboration | - | RNS | ||
| 29.02. | Arecor subsidiary Tetris launching Ogluo in the Netherlands | 1 | Sharecast | ||
| 29.02. | Arecor Therapeutics - Arecor announces launch of Ogluo® in Netherlands | - | RNS | ||
| 01.02. | Arecor Therapeutics hails Arestat as 2023 performance "strong" | 1 | Alliance News | ||
| 01.02. | Arecor Therapeutics - Year End Trading Update | - | RNS | ||
| 23.01. | IN BRIEF: Arecor pleased as investee Inhibrx sells therapy to Sanofi | 4 | Alliance News | ||
| 23.01. | Arecor Therapeutics - Arecor announces update on INBRX-101 | - | RNS | ||
| 18.01. | TRADING UPDATES: Patent boosts for DG Innovate and Arecor Therapeutics | 2 | Alliance News | ||
| 18.01. | Arecor Therapeutics - Arecor granted key European patent | - | RNS | ||
| 08.01. | Arecor expands speciality hospital collaboration with partner | 1 | Alliance News | ||
| 08.01. | Arecor Therapeutics - Expansion of specialty hospital collaboration | - | RNS | ||
| 03.01. | Arecor appoints new commercial manager to Tetris subsidiary | 1 | Sharecast | ||
| 03.01. | Arecor Therapeutics - Appointment of SVP for Tetris Pharma Ltd | 1 | RNS | ||
| 04.12.23 | Arecor inks co-development deal with global medical company | 1 | Alliance News | ||
| 04.12.23 | Arecor inks co-development deal with global medicine company | 1 | Sharecast | ||
| 04.12.23 | Arecor Therapeutics - Agreement with global medical products company | - | RNS |
Seite:
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 9,160 | -4,98 % | Evotec-Aktie: Wann kommt die Trendwende? | Wenige Tage vor der Bekanntgabe neuer Geschäftszahlen kommt die Evotec-Aktie (WKN: 566480) ihrem 12-Monats-Tief, das bei 12,62 € liegt, gefährlich nahe. Während ein Analyst eine frische Kaufempfehlung... ► Artikel lesen | |
| QIAGEN | 37,940 | -1,65 % | QIAGEN N.V.: QIAGEN erweitert Tuberkulose-Portfolio: Neues NGS-Panel unterstützt Echtzeit-Überwachung und Bekämpfung antimikrobieller Resistenzen | QIAseq xHYB Mycobacterium tuberculosis Panel zu Forschungszwecken ermöglicht kulturfreies Whole Genome Sequencing komplexer Proben // Panel beschleunigt Nachverfolgung von TB-Ausbrüchen und unterstützt... ► Artikel lesen | |
| VERA THERAPEUTICS | 38,690 | -3,15 % | Aktien New York Ausblick: Vor dem Start in die Berichtssaison stabil erwartet | NEW YORK (dpa-AFX) - Nach einem schwachen Handelsverlauf am Vortag dürften sich die US-Börsen am Donnerstag stabilisieren. Am Mittwoch hatte eine überraschend hohe Inflation im Monat März die Hoffnungen... ► Artikel lesen | |
| IMMUNOVANT | 27,750 | -3,65 % | Should You Hold Immunovant (IMVT)? | ||
| KYMERA THERAPEUTICS | 33,350 | -5,23 % | Kymera Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) | ||
| RECURSION PHARMACEUTICALS | 7,840 | -1,26 % | Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX | ||
| ARCTURUS THERAPEUTICS | 26,170 | -3,00 % | Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress | SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 44,200 | +1,89 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | ||
| ARCUTIS BIOTHERAPEUTICS | 8,590 | -1,83 % | Arcutis Biotherapeutics, Inc.: Arcutis Appoints David Topper as Chief Financial Officer | WESTLAKE VILLAGE, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage company focused on developing meaningful innovations in immuno-dermatology... ► Artikel lesen | |
| DYNE THERAPEUTICS | 23,695 | -5,14 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer | WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for... ► Artikel lesen | |
| DAY ONE BIOPHARMACEUTICALS | 13,210 | -13,03 % | Day One Biopharmaceuticals, Inc.: Day One's OJEMDA (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor | First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation RAPNO LGG overall response rate... ► Artikel lesen | |
| KEROS THERAPEUTICS | 54,19 | -3,65 % | Prozessmanagement in der Gemeinschaftsverpflegung / Keros Consult optimiert Warenwirtschaft für Eichhof-Stiftung Lauterbach | Düsseldorf (ots) - Ab sofort unterstützt Keros Consult, eine hundertprozentige Tochtergesellschaft der Klüh-Gruppe, die Eichhof-Stiftung Lauterbach bei der Optimierung ihrer Bestell- und Produktionsprozesse... ► Artikel lesen | |
| BEAM THERAPEUTICS | 21,600 | -5,01 % | Expert Ratings For Beam Therapeutics | ||
| SANA BIOTECHNOLOGY | 8,500 | -0,93 % | Sana Biotechnology, Inc. - 8-K, Current Report | ||
| ARVINAS | 31,600 | -2,89 % | Arvinas Inc.: Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer | NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today... ► Artikel lesen |
ARECOR THERAPEUTICS PLC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,530 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
